Insider Transactions in Q4 2020 at Zentalis Pharmaceuticals, Inc. (ZNTL)
Insider Transaction List (Q4 2020)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 24
2020
|
Kevin D. Bunker Chief Scientific Officer |
SELL
Bona fide gift
|
Direct |
1,600
-0.15%
|
-
|
|
Dec 24
2020
|
Cam Gallagher President, Interim CFO |
SELL
Open market or private sale
|
Indirect |
18,473
-56.17%
|
-
|
|
Dec 08
2020
|
Cam Gallagher President, Interim CFO |
SELL
Open market or private sale
|
Direct |
22,573
-0.76%
|
$1,264,088
$56.22 P/Share
|
|
Dec 07
2020
|
Anthony Y Sun President & CEO |
SELL
Open market or private sale
|
Direct |
35,606
-0.44%
|
$1,851,512
$52.87 P/Share
|
|
Dec 07
2020
|
Kevin D. Bunker Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
10,892
-0.26%
|
$566,384
$52.87 P/Share
|
|
Dec 07
2020
|
Epperly Melissa B, Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
6,464
-0.57%
|
$336,128
$52.87 P/Share
|
|
Dec 07
2020
|
Cam Gallagher President, Interim CFO |
SELL
Open market or private sale
|
Direct |
6,692
-0.28%
|
$347,984
$52.87 P/Share
|
|
Dec 04
2020
|
Anthony Y Sun President & CEO |
SELL
Open market or private sale
|
Direct |
39,769
-0.95%
|
$1,988,450
$50.96 P/Share
|
|
Dec 04
2020
|
Kevin D. Bunker Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
12,165
-0.57%
|
$608,250
$50.96 P/Share
|
|
Dec 04
2020
|
Epperly Melissa B, Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
7,220
-1.25%
|
$361,000
$50.96 P/Share
|
|
Dec 04
2020
|
Cam Gallagher President, Interim CFO |
SELL
Open market or private sale
|
Direct |
7,474
-0.61%
|
$373,700
$50.96 P/Share
|
|
Dec 02
2020
|
Epperly Melissa B, Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
3,083
-0.26%
|
$157,233
$51.78 P/Share
|
|
Dec 02
2020
|
Anthony Y Sun President & CEO |
SELL
Open market or private sale
|
Direct |
26,794
-0.32%
|
$1,366,494
$51.27 P/Share
|
|
Dec 02
2020
|
Cam Gallagher President, Interim CFO |
SELL
Open market or private sale
|
Direct |
10,000
-0.4%
|
$510,000
$51.26 P/Share
|
|
Dec 02
2020
|
David Michael Johnson Director |
SELL
Open market or private sale
|
Direct |
12,896
-2.93%
|
$657,696
$51.24 P/Share
|
|
Dec 01
2020
|
Kevin D. Bunker Chief Scientific Officer |
SELL
Open market or private sale
|
Indirect |
8,420
-1.88%
|
$437,840
$52.41 P/Share
|
|
Dec 01
2020
|
Viking Global Investors LP > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
500,000
-11.25%
|
$25,000,000
$50.5 P/Share
|
|
Nov 24
2020
|
Anthony Y Sun President & CEO |
SELL
Open market or private sale
|
Direct |
11,386
-0.18%
|
$523,756
$46.82 P/Share
|
|
Nov 23
2020
|
Cam Gallagher President, Interim CFO |
SELL
Open market or private sale
|
Direct |
10,000
-0.79%
|
$460,000
$46.87 P/Share
|
|
Nov 23
2020
|
Anthony Y Sun President & CEO |
SELL
Open market or private sale
|
Direct |
15,408
-0.36%
|
$708,768
$46.82 P/Share
|
|
Nov 23
2020
|
Kevin D. Bunker Chief Scientific Officer |
SELL
Open market or private sale
|
Indirect |
8,425
-2.85%
|
$387,550
$46.85 P/Share
|
|
Nov 23
2020
|
Kevin D. Bunker Chief Scientific Officer |
BUY
Bona fide gift
|
Indirect |
101,045
+50.0%
|
-
|
|
Nov 23
2020
|
Kevin D. Bunker Chief Scientific Officer |
SELL
Bona fide gift
|
Direct |
101,045
-8.58%
|
-
|
|
Nov 23
2020
|
Epperly Melissa B, Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
3,083
-0.52%
|
$141,818
$46.88 P/Share
|
|
Nov 22
2020
|
Anthony Y Sun President & CEO |
BUY
Bona fide gift
|
Indirect |
213,600
+50.0%
|
-
|
|
Nov 22
2020
|
Anthony Y Sun President & CEO |
SELL
Bona fide gift
|
Direct |
213,600
-10.59%
|
-
|
|
Oct 28
2020
|
Recurium Equity, LLC > 10% Shareholder |
SELL
Other acquisition or disposition
|
Direct |
4,147,940
-99.64%
|
-
|